Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

STEERing an IDeA in Undergraduate Research at a Rural Research Intensive University.

Sens DA, Cisek KL, Garrett SH, Somji S, Dunlevy JR, Sens MA, Conway P, Doze VA.

Acad Pathol. 2017 Oct 13;4:2374289517735092. doi: 10.1177/2374289517735092. eCollection 2017 Jan-Dec.

2.

An IDeA for enhancing undergraduate research at rural primarily undergraduate institutions.

Sens DA, Cisek KL, Conway P, Doze VA.

Adv Physiol Educ. 2017 Sep 1;41(3):464-471. doi: 10.1152/advan.00041.2017.

3.

Long-term α1B-adrenergic receptor activation shortens lifespan, while α1A-adrenergic receptor stimulation prolongs lifespan in association with decreased cancer incidence.

Collette KM, Zhou XD, Amoth HM, Lyons MJ, Papay RS, Sens DA, Perez DM, Doze VA.

Age (Dordr). 2014;36(4):9675. doi: 10.1007/s11357-014-9675-7. Epub 2014 Jul 4.

4.

Norepinephrine controls astroglial responsiveness to local circuit activity.

Paukert M, Agarwal A, Cha J, Doze VA, Kang JU, Bergles DE.

Neuron. 2014 Jun 18;82(6):1263-70. doi: 10.1016/j.neuron.2014.04.038.

5.

GPCRs in stem cell function.

Doze VA, Perez DM.

Prog Mol Biol Transl Sci. 2013;115:175-216. doi: 10.1016/B978-0-12-394587-7.00005-1. Review.

6.

G-protein-coupled receptors in adult neurogenesis.

Doze VA, Perez DM.

Pharmacol Rev. 2012 Jul;64(3):645-75. doi: 10.1124/pr.111.004762. Epub 2012 May 18. Review.

7.

Long-term α1A-adrenergic receptor stimulation improves synaptic plasticity, cognitive function, mood, and longevity.

Doze VA, Papay RS, Goldenstein BL, Gupta MK, Collette KM, Nelson BW, Lyons MJ, Davis BA, Luger EJ, Wood SG, Haselton JR, Simpson PC, Perez DM.

Mol Pharmacol. 2011 Oct;80(4):747-58. doi: 10.1124/mol.111.073734. Epub 2011 Jul 26.

8.

Cardiac and neuroprotection regulated by α(1)-adrenergic receptor subtypes.

Perez DM, Doze VA.

J Recept Signal Transduct Res. 2011 Apr;31(2):98-110. doi: 10.3109/10799893.2010.550008. Epub 2011 Feb 21. Review.

9.

alpha(1A)- and alpha(1B)-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse.

Doze VA, Handel EM, Jensen KA, Darsie B, Luger EJ, Haselton JR, Talbot JN, Rorabaugh BR.

Brain Res. 2009 Aug 18;1285:148-57. doi: 10.1016/j.brainres.2009.06.035. Epub 2009 Jun 18.

10.

alpha1-Adrenergic receptors regulate neurogenesis and gliogenesis.

Gupta MK, Papay RS, Jurgens CW, Gaivin RJ, Shi T, Doze VA, Perez DM.

Mol Pharmacol. 2009 Aug;76(2):314-26. doi: 10.1124/mol.109.057307. Epub 2009 Jun 1.

11.

Noradrenergic depression of neuronal excitability in the entorhinal cortex via activation of TREK-2 K+ channels.

Xiao Z, Deng PY, Rojanathammanee L, Yang C, Grisanti L, Permpoonputtana K, Weinshenker D, Doze VA, Porter JE, Lei S.

J Biol Chem. 2009 Apr 17;284(16):10980-91. doi: 10.1074/jbc.M806760200. Epub 2009 Feb 25.

12.

Regulator of G protein signaling protein suppression of Galphao protein-mediated alpha2A adrenergic receptor inhibition of mouse hippocampal CA3 epileptiform activity.

Goldenstein BL, Nelson BW, Xu K, Luger EJ, Pribula JA, Wald JM, O'Shea LA, Weinshenker D, Charbeneau RA, Huang X, Neubig RR, Doze VA.

Mol Pharmacol. 2009 May;75(5):1222-30. doi: 10.1124/mol.108.054296. Epub 2009 Feb 18.

13.

Alpha-1A adrenergic receptor activation increases inhibitory tone in CA1 hippocampus.

Hillman KL, Lei S, Doze VA, Porter JE.

Epilepsy Res. 2009 Apr;84(2-3):97-109. doi: 10.1016/j.eplepsyres.2008.12.007. Epub 2009 Feb 6.

14.

Alpha2A adrenergic receptor activation inhibits epileptiform activity in the rat hippocampal CA3 region.

Jurgens CW, Hammad HM, Lichter JA, Boese SJ, Nelson BW, Goldenstein BL, Davis KL, Xu K, Hillman KL, Porter JE, Doze VA.

Mol Pharmacol. 2007 Jun;71(6):1572-81. Epub 2007 Mar 6.

PMID:
17341653
15.

Alpha1A-adrenergic receptors are functionally expressed by a subpopulation of cornu ammonis 1 interneurons in rat hippocampus.

Hillman KL, Doze VA, Porter JE.

J Pharmacol Exp Ther. 2007 Jun;321(3):1062-8. Epub 2007 Mar 2.

PMID:
17337632
16.

Localization of the mouse alpha1A-adrenergic receptor (AR) in the brain: alpha1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors.

Papay R, Gaivin R, Jha A, McCune DF, McGrath JC, Rodrigo MC, Simpson PC, Doze VA, Perez DM.

J Comp Neurol. 2006 Jul 10;497(2):209-22.

PMID:
16705673
17.

Adrenergic receptor modulation of hippocampal CA3 network activity.

Jurgens CW, Boese SJ, King JD, Pyle SJ, Porter JE, Doze VA.

Epilepsy Res. 2005 Aug-Sep;66(1-3):117-28.

PMID:
16140503
18.

Adrenergic receptor characterization of CA1 hippocampal neurons using real time single cell RT-PCR.

Hillman KL, Knudson CA, Carr PA, Doze VA, Porter JE.

Brain Res Mol Brain Res. 2005 Oct 3;139(2):267-76.

PMID:
16005103
19.

Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus.

Hillman KL, Doze VA, Porter JE.

J Pharmacol Exp Ther. 2005 Aug;314(2):561-7. Epub 2005 May 20.

PMID:
15908513
20.

Beta1 adrenergic receptor-mediated enhancement of hippocampal CA3 network activity.

Jurgens CW, Rau KE, Knudson CA, King JD, Carr PA, Porter JE, Doze VA.

J Pharmacol Exp Ther. 2005 Aug;314(2):552-60. Epub 2005 May 20.

PMID:
15908512
21.

Comparison of cardiac excitation-contraction coupling in isolated ventricular myocytes between rat and mouse.

Hintz KK, Norby FL, Duan J, Cinnamon MA, Doze VA, Ren J.

Comp Biochem Physiol A Mol Integr Physiol. 2002 Sep;133(1):191-8.

PMID:
12160885
22.

Excitatory actions of norepinephrine on multiple classes of hippocampal CA1 interneurons.

Bergles DE, Doze VA, Madison DV, Smith SJ.

J Neurosci. 1996 Jan 15;16(2):572-85.

23.
24.

Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons.

Cohen GA, Doze VA, Madison DV.

Neuron. 1992 Aug;9(2):325-35.

PMID:
1497896
25.
26.

Synaptic localization of adrenergic disinhibition in the rat hippocampus.

Doze VA, Cohen GA, Madison DV.

Neuron. 1991 Jun;6(6):889-900.

PMID:
1675862
27.
28.

Protein kinases and long-term potentiation.

Meffert MK, Parfitt KD, Doze VA, Cohen GA, Madison DV.

Ann N Y Acad Sci. 1991;627:2-9. Review. No abstract available.

PMID:
1679309
29.

Pharmacokinetic variability of midazolam infusions in critically ill patients.

Shafer A, Doze VA, White PF.

Crit Care Med. 1990 Sep;18(9):1039-41. No abstract available.

PMID:
2394104
30.

Pertussis toxin and 4-aminopyridine differentially affect the hypnotic-anesthetic action of dexmedetomidine and pentobarbital.

Doze VA, Chen BX, Tinklenberg JA, Segal IS, Maze M.

Anesthesiology. 1990 Aug;73(2):304-7.

PMID:
1974396
31.

Outpatient premedication: use of midazolam and opioid analgesics.

Shafer A, White PF, Urquhart ML, Doze VA.

Anesthesiology. 1989 Oct;71(4):495-501.

PMID:
2478048
32.
33.

Benzodiazepine antagonism does not provoke a stress response.

White PF, Shafer A, Boyle WA 3rd, Doze VA, Duncan S.

Anesthesiology. 1989 Apr;70(4):636-9.

PMID:
2564753
34.

Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor.

Segal IS, Vickery RG, Walton JK, Doze VA, Maze M.

Anesthesiology. 1988 Dec;69(6):818-23.

PMID:
2848424
35.

Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia.

Shafer A, Doze VA, Shafer SL, White PF.

Anesthesiology. 1988 Sep;69(3):348-56.

PMID:
3261954
36.

Propofol-nitrous oxide versus thiopental-isoflurane-nitrous oxide for general anesthesia.

Doze VA, Shafer A, White PF.

Anesthesiology. 1988 Jul;69(1):63-71.

PMID:
3291646
37.

Effects of fluid therapy on serum glucose levels in fasted outpatients.

Doze VA, White PF.

Anesthesiology. 1987 Feb;66(2):223-6. No abstract available.

PMID:
3813083
38.

Comparison of propofol with methohexital for outpatient anesthesia.

Doze VA, Westphal LM, White PF.

Anesth Analg. 1986 Nov;65(11):1189-95.

PMID:
3490195

Supplemental Content

Support Center